Of note, we found that NSCLC tumors for patients that were simultaneously high for PD-L1 expression by IHC but not by RNA-seq had a worse response rate (14%) than those with low expression by IHC alone (38%) or with “double low” expression by IHC and RNA-seq (25%). The gene discussed is CD274; the disease is non-small cell lung carcinoma.